Maykin Ho
Director · AGIOS PHARMACEUTICALS, INC.
Individual
- 2025
- Jun 23, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Maykin Ho files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- George Eric Davis - $2.76M in BMRN purchases and sales in the last 12 months
- Sarah Gheuens - $1.55M in AGIO purchases and sales in the last 12 months
- Brian Goff - $1.18M in AGIO purchases and sales in the last 12 months
- Charles Greg Guyer - $997K in BMRN purchases and sales in the last 12 months
- Gregory R. Friberg - $559K in BMRN purchases and sales in the last 12 months
- James William Burns - $265K in AGIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Maykin Ho?
Maykin Ho is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Maykin Ho last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 5 filings going back to 2025.
